NY-ESO-1 peptide SLLMWITQV (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
NY-ESO-1 peptide SLLMWITQV (HLA-A*0201)

NY-ESO-1 peptide SLLMWITQV (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from New York esophageal squamous cell carcinoma-1 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: SLLMWITQV
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

MHC I-Strep HLA-A*0201; BKV LT-antigen (LLLIWFRPV)

MHC I-Strep HLA-A*0201; BKV LT-antigen (LLLIWFRPV)

IBA Lifescience
Więcej
MHC I-Strep HLA-A*0101; SARS-CoV-2 (LTDEMIAQY)

MHC I-Strep HLA-A*0101; SARS-CoV-2 (LTDEMIAQY)

IBA Lifescience
Więcej
MUC1 peptide VPGWGIALL (HLA-B*0702)

MUC1 peptide VPGWGIALL (HLA-B*0702)

IBA Lifescience
Więcej